Novo Owner, Danish Government Back €300 Million Quantum Fund

Novo Nordisk A/S, a leading Danish pharmaceutical company, and the Danish government have announced their backing of a new €300 million quantum venture fund. This fund aims to become the world's largest of its kind, with the goal of strengthening Europe's position in quantum technology development. The fund will be co-managed by Novo Holdings, the investment arm of the Novo Nordisk Foundation, and Quantum Ventures, a specialized quantum technology investment firm. The Danish government's participation underscores its commitment to fostering innovation and technological advancement in the country. The quantum venture fund will focus on investing in early-stage quantum technology startups, providing them with the necessary resources and expertise to drive their growth and development. This initiative is expected to contribute to the expansion of the quantum computing and quantum technology sectors in Europe, potentially leading to new breakthroughs and commercial applications.